Stockscreener 앱 받기
79.49
3.52%
-2.90
시간 외 거래:
79.49
전일 마감가:
$82.39
열려 있는:
$83.16
하루 거래량:
319.93K
Relative Volume:
0.73
시가총액:
$5.65B
수익:
-
순이익/손실:
$-224.29M
주가수익비율:
-22.91
EPS:
-3.47
순현금흐름:
$-153.27M
1주 성능:
+2.00%
1개월 성능:
+1.55%
6개월 성능:
-3.83%
1년 성능:
-3.68%
1일 변동 폭
$79.34
$83.63
1주일 범위
$77.90
$83.63
52주 변동 폭
$61.80
$113.51
Nuvalent Inc Stock (NUVL) Company Profile
명칭
Nuvalent Inc
전화
508-446-2272
주소
ONE BROADWAY, 14TH FLOOR, CAMBRIDGE
NUVL을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
NUVL
Nuvalent Inc
|
79.49 | 5.65B | 0 | -224.29M | -153.27M | -3.47 |
|
VRTX
Vertex Pharmaceuticals Inc
|
484.24 | 124.35B | 11.02B | -535.60M | -978.00M | -2.20 |
|
REGN
Regeneron Pharmaceuticals Inc
|
700.33 | 76.56B | 14.20B | 4.41B | 3.54B | 38.28 |
|
ARGX
Argen X Se Adr
|
644.48 | 39.16B | 1.86B | -40.29M | -1.28B | -0.85 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
250.59 | 32.44B | 2.25B | -278.16M | -42.59M | -2.17 |
|
BNTX
Biontech Se Adr
|
120.01 | 28.77B | 3.30B | -501.07M | 1.03B | -2.1146 |
Nuvalent Inc Stock (NUVL) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-12-30 | 개시 | H.C. Wainwright | Buy |
| 2024-10-24 | 개시 | UBS | Neutral |
| 2024-08-29 | 개시 | Barclays | Overweight |
| 2024-04-17 | 개시 | Jefferies | Buy |
| 2024-04-01 | 업그레이드 | Leerink Partners | Market Perform → Outperform |
| 2024-02-28 | 재개 | Guggenheim | Buy |
| 2024-02-23 | 개시 | Robert W. Baird | Outperform |
| 2023-09-27 | 개시 | Stifel | Buy |
| 2023-08-08 | 개시 | SVB Securities | Market Perform |
| 2023-07-24 | 개시 | Guggenheim | Buy |
| 2023-01-18 | 개시 | Wedbush | Outperform |
| 2022-06-24 | 개시 | BMO Capital Markets | Outperform |
모두보기
Nuvalent Inc 주식(NUVL)의 최신 뉴스
Nuvalent CEO sells stock worth over $2.1 million By Investing.com - Investing.com South Africa
Nuvalent CEO sells stock worth over $2.1 million - Investing.com India
(NUVL) Proactive Strategies - Stock Traders Daily
Nuvalent (NUVL) Projected to Post Quarterly Earnings on Tuesday - MarketBeat
Nuvalent, Inc. (NASDAQ:NUVL) Receives $112.36 Consensus Target Price from Analysts - MarketBeat
Q1 Earnings Estimate for Nuvalent Issued By Leerink Partnrs - MarketBeat
abrdn plc Buys 9,241 Shares of Nuvalent, Inc. (NASDAQ:NUVL) - MarketBeat
Nuvalent, Inc. (NASDAQ:NUVL) Receives $112.36 Consensus PT from Brokerages - Defense World
10 Mid-Cap Stocks Insiders Are Selling Recently - Insider Monkey
Why Insiders Are Selling Nuvalent, Inc. (NUVL) Recently - Insider Monkey
What is Leerink Partnrs' Forecast for Nuvalent Q2 Earnings? - MarketBeat
KBC Group NV Boosts Stock Holdings in Nuvalent, Inc. (NASDAQ:NUVL) - Defense World
What is Leerink Partnrs’ Forecast for Nuvalent Q2 Earnings? - Defense World
Long Term Trading Analysis for (NUVL) - Stock Traders Daily
Nuvalent (NASDAQ:NUVL) Is In A Good Position To Deliver On Growth Plans - Yahoo Finance
The Potential Rise in the Price of Nuvalent Inc (NUVL) following insiders activity - Knox Daily
Nuvalent Inc (NUVL) is looking forward to a strong quarter - SETE News
Top 10 Takeover Targets of 2025 - Genetic Engineering & Biotechnology News
Nuvalent, Inc. (NASDAQ:NUVL) Director Sells $165,580.00 in Stock - MarketBeat
Nuvalent, Inc. (NASDAQ:NUVL) Stock Holdings Raised by SG Americas Securities LLC - MarketBeat
Vanguard Group Inc's Strategic Acquisition of Nuvalent Inc Shares - GuruFocus.com
Nuvalent director Matthew Shair sells shares worth $165,575 - MSN
Nuvalent director Matthew Shair sells shares worth $165,575 By Investing.com - Investing.com Canada
How To Trade (NUVL) - news.stocktradersdaily.com
Bullish Two Hundred Day Moving Average CrossNUVL - Nasdaq
Nuvalent: A First Look (NASDAQ:NUVL) - Seeking Alpha
Is Nuvalent, Inc. (NUVL) Among Billionaire Joseph Edelman’s Long-Term Stock Picks? - Insider Monkey
Nuvalent’s (NUVL) “Buy” Rating Reiterated at HC Wainwright - Defense World
Nuvalent stock reiterates buy rating on FDA approval potential - MSN
Nuvalent CEO Porter James Richard sells shares worth $2.05m - MSN
JPMorgan Chase & Co. Has $3.55 Million Stake in Nuvalent, Inc. (NASDAQ:NUVL) - Defense World
Nuvalent, Inc. (NASDAQ:NUVL) CEO James Richard Porter Sells 27,000 Shares - MarketBeat
Nuvalent CEO Porter James Richard sells shares worth $2.05m By Investing.com - Investing.com Canada
HC Wainwright Reiterates Buy Rating for Nuvalent (NASDAQ:NUVL) - MarketBeat
Nuvalent stock reiterates buy rating on FDA approval potential By Investing.com - Investing.com Canada
Nuvalent's SWOT analysis: biotech stock shows promise amid clinical progress - Investing.com Canada
(NUVL) Trading Report - Stock Traders Daily
Nuvalent, Inc. (NASDAQ:NUVL) Receives Consensus Recommendation of "Moderate Buy" from Brokerages - MarketBeat
Nuvalent Announces Corporate Updates and Anticipated Milestones for 2025 - Defense World
Nuvalent's SWOT analysis: biotech's lung cancer drug stock shows promise amid risks - Investing.com Australia
Nuvalent's SWOT analysis: biotech's lung cancer drug stock shows promise amid risks By Investing.com - Investing.com South Africa
Nuvalent’s (NUVL) Outperform Rating Reaffirmed at Wedbush - Defense World
Nuvalent (NASDAQ:NUVL) Given "Outperform" Rating at Wedbush - MarketBeat
Nuvalent Inc (NUVL) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.27%
3.05%
자본화:
|
볼륨(24시간):